Exhibitor at Fi Europe 2026 stand 51A12 & stand 51A12, Pet Food & Nutrition
As the Chinese innovative leading pharmaceutical enterprise ,CSPC is engaged in Innovative drug research and development, production and sale. CSPC has a total asset of RMB 41 billion and around 25,000 employees up to now. Listed in Hong Kong(01093.HK)with market value of more than HK$ 100 billion and being one of the Hang Seng Index constituent stocks, CSPC has been the first pharmaceutical share since the past 50 years.
All for good medicine, All for mankind’s health. CSPC continuously develops its innovative products and continuously enhances production capacity. For now, it has 1252 production document number and a wide product portfolio. All of these can meet the health needs of people with different diseases.
| Sales markets | Africa; Asia; Central/South America; Eastern Europe; North America; Western Europe |
|---|---|
| Affiliated categories: | Cocoa |Glucose |Vitamin B12 More |
To proceed please sign up (free buyer account) or log in (if you already have an account).
Log in